Background and hypothesis: An important complication of beta-thalassem
ia is iron deposition in cardiac tissues resulting in fibrosis and dys
function. Our aim was the investigation of the possible clinical effec
t of iron loading in the heart of patients with beta-thalassemia prior
to the appearance of symptoms of depressed systolic function. Methods
: Thirty-five patients with beta-thalassemia, of whom 24 had the major
type (Group 1) and 11 had the intermedia type (Group 2) were studied.
Eleven age- and gender-matched controls were also studied (Group 3).
All patients were evaluated echocardiographically and were shown to ha
ve normal left ventricular systolic function and dimensions. Serum fer
ritin, atrial natriuretic peptide (ANP), left atrial diameter (LAD), p
eak early mitral inflow velocity (E), peak late mitral inflow velocity
(A), E/A ratio, deceleration time of the mitral inflow E wave (DT), an
d isovolumic relaxation time (IVRT) were measured. Results: Univariate
analysis showed that both groups of patients had similarly increased
LAD and ANP plasma lev els. Group 1 had a higher E/A ratio (2.27 +/- 0
.88) SS than Group 2(1.69 +/- 0.47, p = 0.05) and Group 3 (1.50 +/- 0.
38, p = 0.01). Serum ferritin was significantly higher in Group 1 (3.5
26 +/- 0.352) than in Group 2 (2.808 +/- 0.288, p < 10(-5)) and Group
3 (2.139 +/- 0.124, p<10(-5)).Multivariate analysis showed that ANP is
a factor that is affected by the LAD and E/A ratio and that serum fer
ritin levels affect the LAD and E/A ratio. Conclusions: Although LAD a
nd ANP levels are increased in patients with beta-thalassemia, the inc
reased serum ferritin levels of patients seem to affect left atrial si
ze and E/A ratio. ANP secretion is consecutively affected by these fac
tors.